Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) CFO Brian Larose Acquires 5,125 Shares – MarketBeat

Share Article

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) CFO Brian Larose acquired 5,125 shares of Petco Health and Wellness stock in a transaction that occurred on Monday, December 6th. The stock was purchased at an average price of $19.45 per share, with a total value of $99,681.25. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of WOOF traded up $1.03 during mid-day trading on Monday, reaching $19.46. 3,458,129 shares of the company’s stock were exchanged, compared to its average volume of 2,613,426. The company has a quick ratio of 0.33, a current ratio of 0.96 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $22.55 and a two-hundred day simple moving average of $22.07. Petco Health and Wellness Company, Inc. has a 52-week low of $17.82 and a 52-week high of $31.08. The company has a market cap of $4.41 billion and a price-to-earnings ratio of 40.54.
Petco Health and Wellness (NASDAQ:WOOF) last released its earnings results on Wednesday, November 17th. The company reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.02. The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Petco Health and Wellness had a net margin of 2.30% and a return on equity of 8.27%. Petco Health and Wellness’s revenue was up 14.6% compared to the same quarter last year. As a group, equities research analysts predict that Petco Health and Wellness Company, Inc. will post 0.76 EPS for the current fiscal year.
A number of research analysts have issued reports on the stock. Jefferies Financial Group cut shares of Petco Health and Wellness from a “buy” rating to a “hold” rating and set a $26.00 target price for the company. in a report on Monday, November 15th. Wedbush raised shares of Petco Health and Wellness from a “neutral” rating to an “outperform” rating and set a $23.00 target price for the company in a report on Monday. Credit Suisse Group raised shares of Petco Health and Wellness from a “neutral” rating to an “outperform” rating and set a $28.00 target price for the company in a report on Friday, August 20th. Evercore ISI reaffirmed a “buy” rating on shares of Petco Health and Wellness in a report on Sunday, August 22nd. Finally, Zacks Investment Research cut shares of Petco Health and Wellness from a “buy” rating to a “hold” rating in a report on Thursday, November 25th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $26.00.
A number of hedge funds have recently added to or reduced their stakes in the business. Psagot Value Holdings Ltd. grew its stake in Petco Health and Wellness by 109.9% in the 3rd quarter. Psagot Value Holdings Ltd. now owns 30,961 shares of the company’s stock worth $653,000 after acquiring an additional 16,211 shares during the period. Summit Trail Advisors LLC grew its stake in Petco Health and Wellness by 0.4% in the 3rd quarter. Summit Trail Advisors LLC now owns 264,000 shares of the company’s stock worth $5,570,000 after acquiring an additional 1,000 shares during the period. Captrust Financial Advisors grew its stake in Petco Health and Wellness by 2,567.1% in the 3rd quarter. Captrust Financial Advisors now owns 15,869 shares of the company’s stock worth $335,000 after acquiring an additional 15,274 shares during the period. Twinbeech Capital LP grew its stake in Petco Health and Wellness by 112.0% in the 3rd quarter. Twinbeech Capital LP now owns 44,292 shares of the company’s stock worth $935,000 after acquiring an additional 23,404 shares during the period. Finally, UBS Group AG grew its stake in Petco Health and Wellness by 25.3% in the 3rd quarter. UBS Group AG now owns 81,606 shares of the company’s stock worth $1,722,000 after acquiring an additional 16,476 shares during the period. 63.86% of the stock is owned by hedge funds and other institutional investors.
Petco Health and Wellness Company Profile
Petco Health and Wellness Company, Inc operates as a retailer of premium pet consumables, supplies, and companion animals and services. The company also offers grooming, in-store and online training, tele-veterinarian, and pet health insurance services, as well as veterinary services through Vetco clinics.
Featured Story: How to start trading in the forex market?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Petco Health and Wellness, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Petco Health and Wellness wasn’t on the list.
While Petco Health and Wellness currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
 
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Each market day you’ll get a one-minute market summary to help you invest wisely.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits
MarketBeat is accredited by the Better Business Bureau
© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness